Lanean...
HEMOLYSATE-MEDIATED PLATELET AGGREGATION: AN ADDITIONAL RISK MECHANISM CONTRIBUTING TO THROMBOSIS OF CONTINUOUS FLOW VENTRICULAR ASSIST DEVICES
Despite the clinical success and growth in the utilization of continuous flow ventricular assist devices (cfVADs) for the treatment of advanced heart failure, hemolysis and thrombosis remain major limitations. Inadequate and/or ineffective anticoagulation regimens, combined with high pump speed and...
Gorde:
| Argitaratua izan da: | Perfusion |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4874907/ https://ncbi.nlm.nih.gov/pubmed/26590166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0267659115615206 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|